About

Hanzhang Wang is a leading researcher in urologic oncology, with a primary focus on advancing minimally invasive surgical techniques for kidney, bladder, and testicular cancers. His most impactful work includes a landmark systematic review and meta-analysis on robotic-assisted radical nephrectomy with inferior vena cava thrombectomy, which has garnered 51 citations and established the safety and feasibility of this complex procedure. Wang has also made significant contributions to the field of robotic retroperitoneal lymph node dissection for testis cancer, with two systematic reviews (31 and 1 citations) that compare perioperative outcomes to open surgery. His research on nationwide trends in robot-assisted radical cystectomy, published in 2022, has been cited 10 times and reveals important predictors for continent urinary diversion. Additionally, Wang has analyzed national incidences of open conversion during minimally invasive partial nephrectomy (9 citations) and compared survival outcomes between minimally invasive and open radical nephrectomy for early-stage renal cell carcinoma (20 citations). Through his systematic reviews and large database analyses, Wang continues to shape evidence-based practice in robotic urologic surgery.

Research Focus

Key Achievements

5
H-Index
6
Papers
122
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes
51 citations · 2022
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: The University of Texas at San Antonio Health Science Center, The University of Texas Health Science Center at Houston

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago